Z-0135-2023 Class III Terminated
FDA device recall Z-0135-2023 was initiated by LumiraDx on Sep 23, 2022 and is designated Class III. Reason for recall: Assigned vial lot numbers for the incorrect type of product. SARS-CoV-2 & Flu A/B lot numbers were incorrectly assigned to the positive and negative vial lot numbers for SARS-CoV-2 Ag LQCs within… The recall status is terminated (terminated Dec 13, 2024). Affected quantity: 83 kits.
Recall details
- Product Type
- Devices
- Report Date
- Nov 2, 2022
- Initiation Date
- Sep 23, 2022
- Termination Date
- Dec 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 83 kits
Product description
LumiraDx SARS-CoV-2 Antigen (Ag) Liquid Quality Control Kit Catalog #: L016080109002 (EUA) The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip. The Quality Controls provide users with assurance that the device is performing within specification
Reason for recall
Assigned vial lot numbers for the incorrect type of product. SARS-CoV-2 & Flu A/B lot numbers were incorrectly assigned to the positive and negative vial lot numbers for SARS-CoV-2 Ag LQCs within batch 2002204017, which should have been assigned SARS-CoV-2 Ag lot numbers resulting in an error message and preventing use of the LQC
Distribution pattern
US Nationwide distribution.
Code information
LQC Kit: 2002204017 Positive Control Vial: 1000 1710 0014 0141 Negative Control Vial: 1000 1720 0014 0142 Exp. Date: 01-Mar-2023
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0135-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026